Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Return on Sales (2016 - 2026)

Avanos Medical's Return on Sales history spans 13 years, with the latest figure at 0.0% for Q3 2025.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.0% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.0%, a 0.0% change, with the full-year FY2024 number at 0.0%, changed 0.0% from a year prior.
  • Return on Sales hit 0.0% in Q3 2025 for Avanos Medical, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Sales for AVNS hit a ceiling of 0.0% in Q2 2021 and a floor of 0.01% in Q4 2021.
  • Historically, Return on Sales has averaged 0.0% across 5 years, with a median of 0.0% in 2025.
  • Biggest five-year swings in Return on Sales: changed 0bps in 2021 and later rose 1bps in 2022.
  • Tracing AVNS's Return on Sales over 5 years: stood at 0.01% in 2021, then skyrocketed by 106bps to 0.0% in 2022, then tumbled by -107bps to 0.0% in 2023, then surged by 42bps to 0.0% in 2024, then skyrocketed by 74bps to 0.0% in 2025.
  • Business Quant data shows Return on Sales for AVNS at 0.0% in Q3 2025, 0.0% in Q2 2025, and 0.0% in Q1 2025.